This company has been acquired
Coeptis Therapeutics Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Wichtige Informationen
n/a
Dividendenausschüttung
n/a
Ausschüttungsquote
| Durchschnittlicher Branchenertrag | 2.2% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Gewinn pro Aktie | -US$0.74 |
| Prognose der Dividendenrendite | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if COEP's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if COEP's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Coeptis Therapeutics Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (COEP) | n/a |
| Untere 25 % des Marktes (US) | 1.4% |
| Markt Top 25 % (US) | 4.3% |
| Branchendurchschnitt (Pharmaceuticals) | 2.2% |
| Analystenprognose (COEP) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: Unable to evaluate COEP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate COEP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as COEP has not reported any payouts.